𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2.204 Levodopa ingestion and metabolism in patients with idiopathic Parkinson's disease

✍ Scribed by F. Adams; M. Boschmann; E. Lobsien; A. García; A. Lipp; G. Franke; M.C. Leisse; S. Gottschalk; J. Spranger; A. Kupsch; J. Jordan

Book ID
117752855
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
56 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cysteine elevation in levodopa-treated p
Cysteine elevation in levodopa-treated patients with Parkinson's disease
✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was